S&P 500 7,609.78 +0.13% NASDAQ 27,093.90 +0.03% DOW 51,307.79 +0.45% R2K 2,931.96 +0.90% VIX 15.77 -1.74%
Next Bullish Trade
ELV Elevance Health, Inc. NYQ
$389.03 -13.63 (-3.38%)
Neutral · +0.45σ
+ Compare Set alert Open in Sniper

Price chart

Overlay: Click earnings ▲ markers for day-move details

Loading 1Y daily…

Financial overlay · last 12 quarters

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $50.2B $1.8B — $4.1B 3.5% —
2025-12-31 $49.7B $0.5B — $-0.2B 1.1% —
2025-09-30 $50.7B $1.2B — $0.8B 2.3% —
2025-06-30 $49.8B $1.7B — $1.8B 3.5% —
2025-03-31 $48.9B $2.2B — $0.8B 4.5% —
2024-12-31 $nanB $nanB — $nanB nan% —
2024-09-30 $nanB $nanB — $nanB nan% —

Earnings replay · last 20 reports

DateEPS actual EPS estSurprise
2026-04-22 12.58 10.81 +16.4%
2026-01-28 3.33 3.09 +7.7%
2025-10-21 6.03 4.94 +22.0%
2025-07-17 8.84 8.92 -0.9%
2025-04-22 11.97 11.48 +4.3%
2025-01-23 3.84 3.85 -0.3%
2024-10-17 8.37 9.65 -13.3%
2024-07-17 10.12 10.01 +1.1%
2024-04-18 10.64 10.53 +1.1%
2024-01-24 5.62 5.59 +0.6%
2023-10-18 8.99 8.46 +6.3%
2023-07-19 9.04 8.78 +3.0%
2023-04-19 9.46 9.28 +2.0%
2023-01-25 5.23 5.19 +0.8%
2022-10-19 7.53 7.15 +5.3%
2022-07-20 8.04 7.74 +3.8%
2022-04-20 8.25 7.83 +5.4%
2022-01-26 5.14 5.12 +0.5%
2021-10-20 6.79 6.37 +6.7%
2021-07-21 7.03 6.34 +10.9%

Earnings markers are overlaid on the price chart above. Transcript summaries require PERPLEXITY_API_KEY (deferred to a follow-up).

Peer comparison · Healthcare

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
ELV ★ $84B 16.5 13.3 0.4 9.3 1.9 25.9% 2.6% -16.8% 5.09%
LLY $949B 37.7 23.9 13.1 27.3 30.5 82.8% 55.5% 169.9% 0.96%
UNH $343B 28.5 18.1 0.8 18.5 3.5 18.8% 2.0% 0.7% 5.15%
JNJ $537B 25.8 17.5 5.6 16.6 6.6 68.0% 9.9% -52.9% 2.33%
MRK $286B 32.6 12.1 4.3 11.2 6.2 76.7% 4.9% — 4.92%
ABBV $381B 105.6 13.3 6.1 14.8 -57.2 72.0% 12.4% -46.2% 5.47%
PFE $146B 19.5 9.0 2.3 7.8 1.6 74.8% 5.4% -10.1% 8.50%
TMO $179B 26.5 17.7 4.0 19.4 3.4 40.9% 6.2% 11.3% 3.08%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Top institutional holders

Top-10 concentration: 39.12%

HolderShares% out
Blackrock Inc. 19,887,111 9.16%
Vanguard Capital Management LLC 14,345,459 6.61%
State Street Corporation 10,288,696 4.74%
Wellington Management Group, LLP 8,228,537 3.79%
Vanguard Portfolio Management LLC 6,356,077 2.93%
Sanders Capital, LLC 5,894,303 2.71%
Geode Capital Management, LLC 5,192,707 2.39%
Artisan Partners Limited Partnership 5,127,175 2.36%
Invesco Ltd. 4,817,410 2.22%
Harris Associates L.P. 4,796,526 2.21%

Insider activity · 90d

No insider trades for ELV in last 90d.

Analyst estimates

yfinance
Low
$331.0
Mean
$407.61905
High
$498.0
Analysts
21

Consensus: buy (mean 1.77273). Distribution requires FINNHUB_API_KEY.

SEC filings

FormFiled DescriptionAction
4 2026-05-20 FORM 4 view ·
4 2026-05-15 FORM 4 view ·
4 2026-05-15 FORM 4 view ·
4 2026-05-15 FORM 4 view ·
4 2026-05-15 FORM 4 view ·
4 2026-05-15 FORM 4 view ·
4 2026-05-15 FORM 4 view ·
4 2026-05-15 FORM 4 view ·
4 2026-05-15 FORM 4 view ·
4 2026-05-15 FORM 4 view ·
4 2026-05-15 FORM 4 view ·
8-K 2026-05-13 8-K view ·
10-Q 2026-04-22 10-Q view ·
8-K 2026-04-22 8-K view ·
DEF 14A 2026-03-27 DEF 14A view ·
4 2026-03-23 FORM 4 view ·
8-K 2026-03-10 8-K view ·
4 2026-03-09 FORM 4 view ·
4 2026-03-06 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
8-K 2026-03-02 8-K view ·
8-K 2026-02-26 8-K view ·
10-K 2026-02-06 10-K view ·
4 2026-02-03 FORM 4 view ·
4 2026-02-03 FORM 4 view ·
8-K 2026-01-28 8-K view ·
8-K 2025-12-10 8-K view ·
8-K 2025-11-10 8-K view ·
10-Q 2025-10-21 10-Q view ·
8-K 2025-10-21 8-K view ·
4 2025-10-03 FORM 4 view ·
8-K 2025-09-15 8-K view ·
4 2025-09-05 FORM 4 view ·
4 2025-09-04 FORM 4 view ·
4 2025-09-04 FORM 4 view ·
8-K 2025-09-04 8-K view ·
4 2025-08-21 FORM 4 view ·
4 2025-08-05 FORM 4 view ·
8-K 2025-07-28 8-K view ·
4 2025-07-18 FORM 4 view ·
10-Q 2025-07-17 10-Q view ·
8-K 2025-07-17 8-K view ·
8-K 2025-05-28 8-K view ·
4 2025-05-16 FORM 4 view ·
4 2025-05-16 FORM 4 view ·
4 2025-05-16 FORM 4 view ·
4 2025-05-16 FORM 4 view ·
4 2025-05-16 FORM 4 view ·
4 2025-05-16 FORM 4 view ·
4 2025-05-16 FORM 4 view ·
4 2025-05-16 FORM 4 view ·
4 2025-05-16 FORM 4 view ·

About

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management…